Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,545,824
+$214,351 QoQ
Shares Held
6,143
+0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#2,154
of 4,153 holders
Holding Since
Sep 2022
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Greenspring Advisors, LLC holds $12,307,212 across 8 Drug Manufacturers - General names. ABBV ranks #4 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,171 | $3,803,392 | |
| 2 | AMGN |
Amgen Inc
|
6,730 | $2,437,067 | |
| 3 | JNJ |
Johnson & Johnson
|
8,433 | $2,141,729 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
6,143 | $1,545,824 | |
| 5 | MRK |
Merck & Co., Inc.
|
7,857 | $1,009,624 | |
| 6 | NVS |
Novartis AG
|
4,173 | $653,992 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,135 | $396,075 | |
| 8 | AZN |
Astrazeneca PLC
|
1,685 | $319,509 |
All Filings in ABBV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,545,824 | 6,143 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,331,473 | 6,122 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,376,195 | 6,023 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $581,396 | 2,511 | Shares | Sole | 2025-10-22 | |
| 2025-03-31 | $770,405 | 3,677 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $459,532 | 2,586 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $510,683 | 2,586 | Shares | Sole | 2024-10-24 | |
| 2023-03-31 | $245,589 | 1,541 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $256,313 | 1,586 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $212,454 | 1,583 | Shares | Sole | 2022-11-02 | |
| No filing history on record for this holder in this stock. | ||||||